Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+0.81%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Consolidated Net Income (2016 - 2025)

Immuron (IMRN) posted Consolidated Net Income of -$3.3 million for Q2 2025, down 7126.84% on a QoQ basis from -$46223.4 in Q3 2024, and up 26.93% year-over-year from -$2.6 million in Q2 2024.

Analysis

Immuron (IMRN) Consolidated Net Income (2016 - 2025) Analysis & Trends

Immuron has reported Consolidated Net Income for 10 years, with the latest figure at -$3.3 million in Q2 2025.

  • On a quarterly basis, Consolidated Net Income rose 26.93% year-over-year to -$3.3 million in Q2 2025; TTM through Jun 2025 was -$10.4 million, a 20.81% decrease from a year earlier, with the FY2026 full-year figure at -$3.8 million, down 7207.34% from the prior year.
  • Consolidated Net Income was -$3.3 million for Q2 2025 at Immuron, down from -$46223.4 in the prior quarter.
  • The five-year high for Consolidated Net Income was -$13260.2 in Q4 2021, with the low at -$6.5 million in Q2 2021.
  • Average Consolidated Net Income over 5 years is -$2.3 million, with a median of -$1.9 million recorded in 2023.
  • The sharpest annual moves came in 2021 and 2022: Consolidated Net Income jumped 68.39% in 2021, then slumped 2558.11% in 2022.
  • Over 5 years, Consolidated Net Income stood at -$13260.2 in 2021, then plunged by 2558.11% to -$352470.5 in 2022, then tumbled by 599.34% to -$2.5 million in 2023, then jumped by 98.12% to -$46223.4 in 2024, then plunged by 7126.84% to -$3.3 million in 2025.
  • The last three Consolidated Net Income figures came in at -$3.3 million (Q2 2025), -$46223.4 (Q3 2024), and -$4.6 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Amgen 221.78 Bn 207.79 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 189.46 Bn 186.20 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 130.47 Bn 122.62 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 82.64 Bn 74.65 Bn 3.93 Bn 1.30 Bn
5 Moderna 72.84 Bn 67.70 Bn 52.00 Mn -782.00 Mn
6 Argenx Se 59.64 Bn 54.46 Bn 1.37 Bn 601.00 Mn
7 Alnylam Pharmaceuticals 33.65 Bn 30.35 Bn 992.69 Mn 164.49 Mn
8 Biogen 33.30 Bn 32.01 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 27.62 Bn 28.31 Bn 1.16 Mn -290.61 Mn
10 Immuron 7.31 Mn -1.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.34 Mn
Sep 9, 2024 -46,223.37
Jun 30, 2024 -4.57 Mn
Dec 31, 2023 -2.46 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -352,470.52
Dec 31, 2021 -13,260.17
Jun 30, 2021 -6.46 Mn
Dec 31, 2020 -41,946.68
Jun 30, 2020 -1.92 Mn
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.79 Mn
Dec 31, 2016 2.57 Mn
Jun 30, 2016 -3.28 Mn
API Access

Immuron Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=IMRN&period=max&api_key=YOUR_API_KEY